Mounjaro Alternatives Compared: Weight Loss, Price, Coverage
6 other FDA-approved GLP-1 medicines share a use with Mounjaro: Ozempic, Wegovy, Rybelsus, Trulicity, Victoza and Byetta. Wegovy and Rybelsus are tablets, if you want to avoid needles. The lowest self-pay start among them is $149 per month for Wegovy.
- Same-use GLP-1 options
- 6
- Needle-free options
- Wegovy and Rybelsus
- Lowest self-pay alternative
- $149 per month, Wegovy
Mounjaro in brief
Its half-life is about 5 days: after 5 d, half is gone, and after five half-lives (25 d), about 3% is left.
In type 2 diabetes, the SURPASS-1 trial of 40 weeks showed 7.8 kg lost, and placebo showed 1 kg.
Price points each month in US dollars, covering list price and self-pay offers, all read from the maker's price page.
Sources: FDA label (DailyMed), healthsystemtracker.org, pricinginfo.lilly.com.
Prescription alternatives to Mounjaro
| Medicine | Ingredient | How it is taken | Shared use | Trial weight loss | Self-pay from |
|---|---|---|---|---|---|
 Ozempic | semaglutide | weekly injection | heart risk and type 2 diabetes | Not listed | $199 per month |
 Wegovy | semaglutide | weekly injection or daily tablet | heart risk | 14.9% | $149 per month |
 Rybelsus | semaglutide | daily tablet | heart risk and type 2 diabetes | Not listed | Not listed |
 Trulicity | dulaglutide | weekly injection | heart risk and type 2 diabetes | Not listed | Not listed |
 Victoza | liraglutide | daily injection | heart risk and type 2 diabetes | Not listed | Not listed |
| Byetta | exenatide | twice-daily injection | type 2 diabetes | Not listed | Not listed |
Sources: TrumpRx, FDA label (DailyMed).